Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Trial details
- Registry ID
- NCT02709512
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
Also recorded as Carboplatin; Cisplatin; Pemetrexed
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and CisplatinNCT02709512 | Polaris Group | Phase 2, Phase 3 | Completed | 2022-08-15Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |